AXGN AxoGen, Inc. logo

AXGN AxoGen, Inc.

Healthcare
$41.45+1.34%ClosedMarket Cap: $2.20B

As of 2026-05-26

Valuation

View Details

P/E (TTM)

PEG

P/B

8.62

P/S

9.13

EV/EBITDA

371.09

DCF Value

$-21.93

FCF Yield

0.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

75.0%

Operating Margin

-3.8%

Net Margin

-13.2%

ROE

-20.7%

ROA

-10.9%

ROIC

-3.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$61.5M$-19.6M$
Q4 null$59.9M$-13.2M$
FY null$225.2M$-15.7M$
Q3 null$60.1M$708.0K$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$43.43

Target (Median)

$40.00

Target Range

$36.00 - $50.00

2 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
CitizensMarket Outperform
2026-04-29
HC Wainwright & Co.Buy
2026-04-29
Wells FargoOverweight
2026-04-29
Canaccord GenuityBuy
2026-04-29
Lake StreetBuy
2026-04-23

Trading Activity

Insider Trades

View All
Wendell Amy McBridedirector
SellTue May 12
Wendell Amy McBridedirector
SellTue May 12
Weiler Kathy Johnsondirector
SellFri May 08
Weiler Kathy Johnsondirector
SellFri May 08
Kemp Jensofficer: Chief Marketing Officer
SellFri May 08

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.17

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

Peers